Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures .
D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D016017:Odds Ratio; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D058866:Osteoporotic Fractures / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D012306:Risk; D013997:Time Factors; D016903:Drug Monitoring
D050071:Bone Density Conservation Agents; D004164:Diphosphonates